Bayer expands German manufacturing facilities to fulfill supply demand
Pharmaceutical Technology
NOVEMBER 24, 2023
Bayer announced the launch of a Berlin, Germany-based manufacturing facility to meet future demands from the US, China and Europe.
Fri.Nov 24, 2023
264 
NHS urges individuals to take up cervical screening invitations
Pharma Times
NOVEMBER 24, 2023
Around 3,200 new cases of cervical cancer are diagnosed in the UK every year - News - PharmaTimes
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
F. Hoffmann-La Roche sees highest patent filings and grants during August in Q3 2023
Pharmaceutical Technology
NOVEMBER 24, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for F. Hoffmann-La Roche here.
Study suggests cognitive decline could be linked to hippocampus shrinkage
Pharma Times
NOVEMBER 24, 2023
The findings could benefit patients living with neurodegenerative conditions - News - PharmaTimes
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Johnson & Johnson sees highest patent filings and grants during August in Q3 2023
Pharmaceutical Technology
NOVEMBER 24, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Johnson & Johnson here.
How to optimise commercial-scale ATMP manufacturing through automation
pharmaphorum
NOVEMBER 24, 2023
How to optimise commercial-scale ATMP manufacturing through automation Mike.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
International Health Partners' Christmas campaign: Working with pharma for patients worldwide
pharmaphorum
NOVEMBER 24, 2023
International Health Partners' Christmas campaign: Working with pharma for patients worldwide Nicole.
Novartis sees highest patent filings and grants during August in Q3 2023
Pharmaceutical Technology
NOVEMBER 24, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Novartis here.
Postum: A Time-Honored Coffee Alternative
XTalks
NOVEMBER 24, 2023
In the world of hot beverages, Postum occupies a unique place. Originating as a coffee alternative, this drink has carved out a niche among those seeking a caffeine-free option. To understand its enduring appeal, let’s delve into its history, ingredients and its status in today’s beverage market. The Birth of Postum Postum was born out of necessity.
Bristol-Myers Squibb sees highest patent filings and grants during August in Q3 2023
Pharmaceutical Technology
NOVEMBER 24, 2023
Access and buy GlobalData’s databook on the latest filings and grants activity for Bristol-Myers Squibb here.
Calliditas Therapeutics' partner Everest Medicines' announces kidney drug approval
Outsourcing Pharma
NOVEMBER 24, 2023
Calliditas Therapeutics AB announced today (November 24) that its partner Everest Medicines has revealed that China's National Medical Products Administration (NMPA) has approved Nefecon.
Sosei to regain rights to IBD drug after GSK discontinues programme
Pharmaceutical Technology
NOVEMBER 24, 2023
The Sosei Heptares oral IBD drug was first licensed to GSK in 2020 and is currently in Phase I clinical development.
Progress for Johnson & Johnson's lung cancer drug as extension submitted to EMA
Outsourcing Pharma
NOVEMBER 24, 2023
The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).
Vertex obtains EC approval for combination therapy to treat CF
Pharmaceutical Technology
NOVEMBER 24, 2023
Vertex Pharmaceuticals has obtained approval from EC) for the label expansion of Kaftrio plus ivacaftor to treat children with CF.
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Which pharmaceutical drugs have the most drug patents in Croatia?
Drug Patent Watch
NOVEMBER 24, 2023
This chart shows the drugs with the most patents in Croatia. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.… The post Which pharmaceutical drugs have the most drug patents in Croatia? appeared first on DrugPatentWatch - Make Better Decisions.
Novo Nordisk expands site to manufacture GLP-1 drugs
Pharmaceutical Technology
NOVEMBER 24, 2023
The expansion comes as Novo is trying to maintain strong growth in T2D after the launch of Eli Lilly’s Zepbound this month.
New patent for Abbvie drug RINVOQ
Drug Patent Watch
NOVEMBER 24, 2023
Annual Drug Patent Expirations for RINVOQ Rinvoq is a drug marketed by Abbvie and is included in one NDA. It is available from one supplier. There are twenty-six patents protecting… The post New patent for Abbvie drug RINVOQ appeared first on DrugPatentWatch - Make Better Decisions.
China’s NMPA approves ArkBio’s RSV neutralising antibody drug
Pharmaceutical Technology
NOVEMBER 24, 2023
China’s NMPA has approved ArkBio IND application for its respiratory syncytial virus (RSV) neutralising antibody, AK0610.
New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR)
Drug Patent Watch
NOVEMBER 24, 2023
Annual Drug Patent Expirations for XYOSTED+%28AUTOINJECTOR%29 Xyosted (autoinjector) is a drug marketed by Antares Pharma Inc and is included in one NDA. It is available from one supplier. There are… The post New patent for Antares Pharma drug XYOSTED (AUTOINJECTOR) appeared first on DrugPatentWatch - Make Better Decisions.
Lupin introduces triple combination Vilfuro-G in India for COPD
Pharmaceutical Technology
NOVEMBER 24, 2023
Lupin has introduced the fixed-dose triple combination drug (FDC), Vilfuro-G, to manage chronic COPD in India.
NHS Confederation, ABPI say break down barriers to partnerships and change the lives of millions
pharmaphorum
NOVEMBER 24, 2023
NHS Confederation, ABPI say break down barriers to partnerships and change the lives of millions Nicole.
What’s in a name: Agencies struggle to keep up with expanding drug space
Pharmaceutical Technology
NOVEMBER 24, 2023
With more approved drugs coming through than ever before, the need to avoid confusing names to ensure patient safety is important.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Intellectual property: Striking the balance
pharmaphorum
NOVEMBER 24, 2023
Intellectual property: Striking the balance Mike.
Ellipses receives orphan drug designation for selective RET inhibitor
Pharmaceutical Technology
NOVEMBER 24, 2023
Ellipses Pharma has secured ODD from the US FDA for its next generation EP0031/A400, to potentially treat solid tumours.
Progress for Johnson & Johnson's lung cancer drug as extension submitted to EMA
Outsourcing Pharma
NOVEMBER 24, 2023
The Janssen Pharmaceutical Companies of Johnson & Johnson announced last week (November 23) the submission of a type 2 extension of indication application to the European Medicines Agency (EMA).
Health Canada approves Jazz’s cannabis derived seizure therapy
Pharmaceutical Technology
NOVEMBER 24, 2023
Epidiolex has been approved as an adjunct therapy for seizures associated with three rare forms of epilepsy in patients aged two and older.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Let's personalize your content